Advertisement

The Nutshell

» disease/medicine and genetics & genomics

Daily News Roundup

Most Recent

image: FDA Gives Nod to Melanoma Drug

FDA Gives Nod to Melanoma Drug

By | September 8, 2014

The US Food and Drug Administration last week approved the first of a new type of immunotherapy that aims to pit a patient’s own immune system against her cancer.

2 Comments

image: Arctic Expansion

Arctic Expansion

By | September 2, 2014

Genetic analysis reveals the history of the earliest human migrations in the region.

0 Comments

image: NIH Issues Genomic Data Sharing Rules

NIH Issues Genomic Data Sharing Rules

By | August 28, 2014

Updated guidelines expand upon existing policy to include more kinds of data. 

0 Comments

image: Roots of Alcohol Dependence?

Roots of Alcohol Dependence?

By | August 27, 2014

Researchers link a gene already tied to alcohol dependence with a neurotransmitter involved in anxiety and relaxation.

0 Comments

image: Social Data for Ebola Surveillance

Social Data for Ebola Surveillance

By | August 26, 2014

Algorithms that map social media posts and mobile phone data can help researchers track epidemics.

0 Comments

image: Marburg Drug Shows Promise

Marburg Drug Shows Promise

By | August 22, 2014

Monkeys infected with lethal doses of Marburg virus were rescued by an experimental siRNA-based therapeutic, a study shows.

0 Comments

image: RNA-based Sex Determination?

RNA-based Sex Determination?

By | August 20, 2014

Researchers find that microRNAs may play a role some of the sexual differences seen in fruit flies.

1 Comment

image: DARPA Challenge to Predict Chikungunya Spread

DARPA Challenge to Predict Chikungunya Spread

By | August 19, 2014

Contest aims to identify models that accurately forecast outbreaks.

0 Comments

image: Chikungunya Vaccine Clears Phase 1

Chikungunya Vaccine Clears Phase 1

By | August 18, 2014

Early-stage clinical trial yields promising results. 

0 Comments

image: Biotech Terminates IPO

Biotech Terminates IPO

By | August 15, 2014

The Israeli firm Vascular Biogenics withdrew its initial public offering after six days of trading. 

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Eppendorf
Eppendorf
Advertisement
NeuroScientistNews
NeuroScientistNews